Search by Drug Name or NDC
NDC 68382-0856-77 triamterene and hydrochlorothiazide 25; 37.5 mg/1; mg/1 Details
triamterene and hydrochlorothiazide 25; 37.5 mg/1; mg/1
triamterene and hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is HYDROCHLOROTHIAZIDE; TRIAMTERENE.
MedlinePlus Drug Summary
The combination of triamterene and hydrochlorothiazide is used to treat high blood pressure and edema (fluid retention; excess fluid held in body tissues) in patients who have lower amounts of potassium in their bodies or for whom low potassium levels in the body could be dangerous. The combination of triamterene and hydrochlorothiazide is in a class of medications called diuretics ('water pills'). They work by causing the kidneys to get rid of unneeded water and salt from the body into the urine. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 68382-0856-77Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Triamterene and Hydrochlorothiazide
Product Information
| NDC | 68382-0856 |
|---|---|
| Product ID | 68382-856_e0a51d55-991a-463a-a382-428f33488d77 |
| Associated GPIs | 37990002300315 |
| GCN Sequence Number | 008176 |
| GCN Sequence Number Description | triamterene/hydrochlorothiazid TABLET 37.5-25 MG ORAL |
| HIC3 | R1L |
| HIC3 Description | POTASSIUM SPARING DIURETICS IN COMBINATION |
| GCN | 88741 |
| HICL Sequence Number | 003647 |
| HICL Sequence Number Description | TRIAMTERENE/HYDROCHLOROTHIAZIDE |
| Brand/Generic | Generic |
| Proprietary Name | triamterene and hydrochlorothiazide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | triamterene and hydrochlorothiazide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25; 37.5 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
| Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
| Pharmaceutical Class | Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208360 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68382-0856-77 (68382085677)
| NDC Package Code | 68382-856-77 |
|---|---|
| Billing NDC | 68382085677 |
| Package | 10 BLISTER PACK in 1 CARTON (68382-856-77) / 10 TABLET in 1 BLISTER PACK (68382-856-30) |
| Marketing Start Date | 2018-09-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |